hypoglycemia and glp-1 In type 1 patients with residual ß-cell function, treatment glp 1 reactive hypoglycemia Schematic
Description
doi: 10.1152/ajpendo.00642.2007
Key Takeaways GLP-1 receptor agonists are mainly used for weight management and diabetes, but they also seem to affect the brain
Notably, chemical chaperones (4-PBA, TUDCA) enhance Gq signaling without reversing this switch, while ER stress-associated UPR factors XBP1 and ATF6 selectively amplify Gs signaling
Glucose concentrations were determined using an enzymatic, colorimetric method on Roche/Hitachi Cobas c systems
Torkildsen SE, Svendsen H, Risnen S, et al
